Metformin in type 2 diabetes

Journal of Family Practice

Volumn 53, Issue 11, 2004, Pages 900-

  Fox, Gary N ^a  

^a MERCY HEALTH PARTNERS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; GLIBENCLAMIDE; METFORMIN; METOPROLOL; OMEPRAZOLE; ROFECOXIB;

ADULT; ANAMNESIS; BICARBONATE BLOOD LEVEL; BLOOD PRESSURE; BREATHING RATE; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LETTER; LEUKOCYTE COUNT; NON INSULIN DEPENDENT DIABETES MELLITUS; UREA NITROGEN BLOOD LEVEL; UREMIA;

ACIDOSIS, LACTIC; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; MIDDLE AGED; RISK FACTORS;

EID: 8144228136     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (1)

1. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Arch Intern Med 2003; 163:2594-2602.